GE HealthCare Launches Upgrade Options for Interventional Systems
New pathways allow health systems to update legacy imaging equipment with artificial intelligence and workflow tools while preserving existing infrastructure.
New pathways allow health systems to update legacy imaging equipment with artificial intelligence and workflow tools while preserving existing infrastructure.
The appointment aims to accelerate the development of AI-powered healthcare supply chain solutions and data-driven platform capabilities.
A side-by-side look at platforms used by HTM teams to identify connected devices, prioritize risk, and manage cybersecurity across hospital environments.
New pathways allow health systems to update legacy imaging equipment with artificial intelligence and workflow tools while preserving existing infrastructure.
Routine electrical safety testing is frequently defended on instinct rather than evidence. An engineering analysis shows what actually protects patients and staff.
The new system is designed to support clinical assessment of gastrointestinal, liver, and pancreatic diseases.
The low-profile overlay is designed for use during extended surgeries to reduce the risk of hospital-acquired pressure injuries.
The technology is no longer a standalone tool, but connective tissue linking devices, data, and clinical workflows.
The additions expand testing capabilities with support for global standards and manual measurement mode.
The pediatric body array coil, developed to offer a more flexible alternative to rigid devices, is optimized and validated for use on 3.0T MRI systems.
The new EB-710US device aims to reduce infection risks and streamline procedure preparation by eliminating the use of disposable balloons.
The device features technology that automatically adjusts oxygen delivery to a patient’s breathing rate, a feature recently evaluated in a university bench study.
AI is starting to touch maintenance, documentation, and device risk management in practical ways. Here’s where HTM leaders are likely to see the biggest impact in 2026.
The study will evaluate a second-generation robotic platform in complex catheterization lab procedures.